Fighting hepatitis C virus with peptide nanotubes

Ashraf Brik

doi:10.1016/j.chembiol.2011.11.003

Fighting hepatitis C virus with peptide nanotubes

Ashraf Brik

Department of Chemistry

Research output: Contribution to journal › Short survey › peer-review

Abstract

There is an urgent need to develop effective therapies against hepatitis C virus with different modes of action from limited options already available. In this issue, Montero and coworkers present a detailed study on using peptide nanotubes to effectively block the entry of HCV into target cells.

Original language	English
Pages (from-to)	1347-1348
Number of pages	2
Journal	Chemistry and Biology
Volume	18
Issue number	11
DOIs	https://doi.org/10.1016/j.chembiol.2011.11.003
State	Published - 23 Nov 2011

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmacology
Drug Discovery
Clinical Biochemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.chembiol.2011.11.003

Cite this

@article{68011a063b3345a29a40fbff9cbbb82c,

title = "Fighting hepatitis C virus with peptide nanotubes",

abstract = "There is an urgent need to develop effective therapies against hepatitis C virus with different modes of action from limited options already available. In this issue, Montero and coworkers present a detailed study on using peptide nanotubes to effectively block the entry of HCV into target cells.",

author = "Ashraf Brik",

year = "2011",

month = nov,

day = "23",

doi = "10.1016/j.chembiol.2011.11.003",

language = "English",

volume = "18",

pages = "1347--1348",

journal = "Cell Chemical Biology",

issn = "2451-9448",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Fighting hepatitis C virus with peptide nanotubes

AU - Brik, Ashraf

PY - 2011/11/23

Y1 - 2011/11/23

N2 - There is an urgent need to develop effective therapies against hepatitis C virus with different modes of action from limited options already available. In this issue, Montero and coworkers present a detailed study on using peptide nanotubes to effectively block the entry of HCV into target cells.

AB - There is an urgent need to develop effective therapies against hepatitis C virus with different modes of action from limited options already available. In this issue, Montero and coworkers present a detailed study on using peptide nanotubes to effectively block the entry of HCV into target cells.

UR - http://www.scopus.com/inward/record.url?scp=82255181178&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2011.11.003

DO - 10.1016/j.chembiol.2011.11.003

M3 - Short survey

AN - SCOPUS:82255181178

SN - 2451-9448

VL - 18

SP - 1347

EP - 1348

JO - Cell Chemical Biology

JF - Cell Chemical Biology

IS - 11

ER -

Fighting hepatitis C virus with peptide nanotubes

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this